🧬 #OVCEnterprise# Chime #Biologics# is a biopharma #CDMO# super factory, with overseas orders growing exponentially. Its one‑stop solutions, consistent quality, lower costs, and faster delivery win clients across the US, Europe, South Korea and Japan. #WorldOVC#

Mexico has become the first country outside China to approve the vaccine developed by CanSino Biologics, making it the third Chinese-developed jab to get the go-ahead overseas

Today we announced that the U.S. Food and Drug Administration has approved the supplemental Biologics License Applications for the 2026-2027 formulas for Spikevax® (COVID-19 Vaccine, mRNA) and mNEXSPIKE® (COVID-19 Vaccine, mRNA), containing the JN.1-lineage XFG subvariant of SARS-CoV-2 to help prevent COVID-19. Read more:

HHS laid out its latest strategies to speed the shift away from using animals in medical testing. Beginning next February, research methods other than animal testing can be used when “appropriate” for determining the safety of drugs and biologics, according to a final FDA rule issued yesterday. At the same time, the NIH unveiled several initiatives designed to encourage the use of non-animal approaches such as cell-based assays, organs-on-a-chip, and computer models. STAT’s Ed Silverman wrote about the new policies and spoke with advocates on both sides of the long-running debate. Read more.

HHS ANNOUNCES KEY FDA LEADERSHIP APPOINTMENTS, NAMING JARED SEEHAFER AS THE AGENCY’S FIRST DEPUTY COMMISSIONER FOR TECHNOLOGY & ARTIFICIAL INTELLIGENCE, ALONGSIDE NEW HEADS FOR TOBACCO, BIOLOGICS & DRUG EVALUATION CENTERS.

i spent the summer with 200 founders the word "cracked" is an understatement... • autonomous tuna boats • robots that fix other robots • on-demand CNC prototyping •brain-sensing wearables • cursor for hardware • AI-native biologics friday they're all demoing live. investors in sf, reply "demo" and i'll send you the details + 3 teams you should meet :)

In a stabilizing move, the Department of Health and Human Services has tapped Michael Davis, M.D., Ph.D., and Karim Mikhail—who’ve been serving as acting directors of the Centers for Drugs Evaluation and Research (CDER) and the Centers for Biologics Evaluation and Research (CBER), respectively—to occupy their posts on a permanent basis.